Page last updated: 2024-09-03

gefitinib and Li-Fraumeni Syndrome

gefitinib has been researched along with Li-Fraumeni Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fukuda, K; Kodama, K; Nanjyo, H; Shibata, H; Shimazu, K; Taguchi, D; Takahashi, S; Takahashi, T; Yoshida, T	1

Other Studies

1 other study(ies) available for gefitinib and Li-Fraumeni Syndrome

Article	Year
Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs12. Japanese journal of clinical oncology, 2020, Sep-28, Volume: 50, Issue:10* Topics: Acrylamides; Adenocarcinoma of Lung; Adult; Aniline Compounds; Bone Neoplasms; Female; Gefitinib; Germ-Line Mutation; Humans; Li-Fraumeni Syndrome; Lung Neoplasms; Male; Pedigree; Protein Kinase Inhibitors; Tumor Suppressor Protein p53	2020

Article

Year

Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.

Japanese journal of clinical oncology, 2020, Sep-28, Volume: 50, Issue:10

Topics: Acrylamides; Adenocarcinoma of Lung; Adult; Aniline Compounds; Bone Neoplasms; Female; Gefitinib; Germ-Line Mutation; Humans; Li-Fraumeni Syndrome; Lung Neoplasms; Male; Pedigree; Protein Kinase Inhibitors; Tumor Suppressor Protein p53

2020